Ryan Mee, CEO of Fulcrum Metals, reviews FY23 and progress on the Gold Tailings Hub in Canada. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksReneuron Share News (RENE)

  • This share is currently suspended. It was suspended at a price of 3.275

Share Price Information for Reneuron (RENE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.275
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 3.275
RENE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

EXECUTIVE CHANGES: Long-serving Hansard and Northbridge CEOs retire

Fri, 12th Mar 2021 15:39

(Alliance News) - The following is a round-up of London-listed company director and manager changes announced on Friday and not separately reported by Alliance News:

----------

Hansard Global PLC - Isle of Man-based specialist long-term savings provider - Gordon Marr to retire by the end of 2021 after 8 years as chief executive officer and 30 years with the company. Has initiated a search for a new CEO. "I have decided to announce my retirement plans now, providing ample time to identify a successor and ensure a smooth transition," Marr says. "I am committed to leading the company in the meantime, as we remain resolutely focused on delivering a solid performance in 2021, while positioning the company for further success in the future."

----------

Northbridge Industrial Services PLC - Burton on Trent, England-based firm that hires and sells specialist industrial equipment - CEO & Founder Eric Hook will step down from the board on March 31 after 15 years in post but remain as an advisor and significant shareholder. Chair Peter Harris will become executive chair with the directors of Northbridge's two divisions - Chris Caldwell of Crestchic and Ian Gardner of Tasman - reporting to him. Additionally Caldwell will be promoted to the board. Non-Executive Director Stephen Yapp is promoted to senior independent director, while Ash Mehta will step down as non-executive director.

----------

ReNeuron Group PLC - Bridgend, Wales-headquartered cell-based therapeutics - Chief Financial Officer Michael Hung resigns on Thursday "in order to pursue other projects", having joined the board in early 2001. Hung will remain until the end of May, and ReNeuron have started a search for his replacement.

----------

Anpario PLC - Nottinghamshire-based sustainable animal feed additives - Hires Ian Hamilton as non-executive director, starting April 1. Hamilton was in the founding management team of poultry breeding business Aviagen. He currently is non-executive chair of Horizon Proteins Ltd, which provides sustainable proteins for aquaculture recycled from the whiskey-making process, and of Biotangents Ltd, a veterinary diagnostics business.

----------

Gooch & Housego PLC - Ilminster, Somerset-based maker of optical components - Hires Jim Haynes as non-executive director, starting Friday. Haynes was executive vice president of operations at US optical components firm Oclaro Inc, which was bought by Lumentum Holdings Inc at the end of 2018.

----------

Universe Group PLC - Southampton, Hampshire-based retail management, payment and loyalty systems - Hires Neil Radley as CEO, joining Universe Group on May 1. Most recently, Radley led Jaja Finance Ltd, a fintech lending firm. He also has worked at Barclaycard, HBOS PLC and Bank One International. Radley replaces Jeremy Lewis, who the company last month said will leave on April 30 "to pursue other opportunities outside of the public markets", after seven years with Universe.

----------

By Tom Waite; thomaslwaite@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
26 Oct 2021 19:06

TRADING UPDATES: Yellow Cake fundraises; Mercia Asset invests

TRADING UPDATES: Yellow Cake fundraises; Mercia Asset invests

Read more
26 Oct 2021 14:02

ReNeuron enters cancer therapy collaboration with UCL

(Sharecast News) - Cell-based therapeutic specialist ReNeuron has entered a collaboration agreement with University College London (UCL), it announced on Tuesday, to conduct research into the generation of immune cells from induced pluripotent stem cells (iPSCs), for anti-cancer cell therapies.

Read more
21 Oct 2021 16:40

Director dealings: Reneuron Group non-executive makes share purchase

(Sharecast News) - Reneuron Group revealed on Thursday that non-executive director Barbara Staehelin had acquired 43,000 ordinary shares in the AIM-listed cell-based therapeutics developer.

Read more
21 Oct 2021 14:07

DIRECTOR DEALINGS: Inspiration Healthcare exec sells 135,000 shares

DIRECTOR DEALINGS: Inspiration Healthcare exec sells 135,000 shares

Read more
18 Oct 2021 15:12

TRADING UPDATES: Mind Gym revenue recovers; Dispersion buys Accru

TRADING UPDATES: Mind Gym revenue recovers; Dispersion buys Accru

Read more
18 Oct 2021 09:14

ReNeuron treats first Oxford patient as part of expanded study

(Sharecast News) - Cell-based therapeutics developer ReNeuron Group said on Monday that the first UK subject had been treated at the Oxford Eye Hospital as part of its phase 2a clinical evaluations for the treatment of retinitis pigmentosa (RP) - an inherited, degenerative eye disease.

Read more
11 Oct 2021 11:51

ReNeuron upbeat on positive data from Spain collaboration

(Sharecast News) - Exosome therapeutics developer ReNeuron announced positive data on Monday that it said provided "clear preclinical proof-of-concept" that its novel exosome drug delivery technology could effectively deliver therapeutic proteins to the specific region of the brain affected by several neurological diseases.

Read more
11 Oct 2021 11:05

IN BRIEF: ReNeuron gets positive results from exosome drug data

IN BRIEF: ReNeuron gets positive results from exosome drug data

Read more
11 Oct 2021 10:59

AIM WINNERS & LOSERS: Cadence rises on Amapa "landmark"; ASOS dives

AIM WINNERS & LOSERS: Cadence rises on Amapa "landmark"; ASOS dives

Read more
1 Oct 2021 11:15

TRADING UPDATES: Sensyne revenue jumps; Stranger Holdings loss narrows

TRADING UPDATES: Sensyne revenue jumps; Stranger Holdings loss narrows

Read more
1 Oct 2021 10:33

ReNeuron gets approval to restart RP clinical study

(Sharecast News) - Cell-based therapeutics developer ReNeuron Group updated the market on its phase 2a clinical evaluations for the treatment of the inherited, degenerative eye disease retinitis pigmentosa on Friday, confirming that it had received regulatory approval to restart the study in all geographies.

Read more
9 Sep 2021 16:01

UK shareholder meetings calendar - next 7 days

UK shareholder meetings calendar - next 7 days

Read more
6 Aug 2021 10:55

ReNeuron taps Oxford Biomedica executive Catherine Isted as CFO

ReNeuron taps Oxford Biomedica executive Catherine Isted as CFO

Read more
14 Jul 2021 15:15

IN BRIEF: ReNeuron hires Swiss exec as senior independent director

IN BRIEF: ReNeuron hires Swiss exec as senior independent director

Read more
8 Jul 2021 11:38

TRADING UPDATES: Jet2 swings to loss; Hyve Group sees busiest quarter

TRADING UPDATES: Jet2 swings to loss; Hyve Group sees busiest quarter

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.